Approval · Notice of Compliance 9703 · 2008
FOSAVANCE: Notice of Compliance 9703
Issued August 6, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9703
- Date
- August 6, 2008
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- NEW STRENGTH: 70mg/140mcg
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FOSAVANCE | 02314940 | Marketed |
Medicinal ingredients
- ALENDRONIC ACID 70 MG per TAB
- VITAMIN D3 5,600 UNIT per TAB